JP2017513927A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513927A5
JP2017513927A5 JP2016575314A JP2016575314A JP2017513927A5 JP 2017513927 A5 JP2017513927 A5 JP 2017513927A5 JP 2016575314 A JP2016575314 A JP 2016575314A JP 2016575314 A JP2016575314 A JP 2016575314A JP 2017513927 A5 JP2017513927 A5 JP 2017513927A5
Authority
JP
Japan
Prior art keywords
solution
item
self
target area
assembling peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016575314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/019738 external-priority patent/WO2015138473A1/en
Publication of JP2017513927A publication Critical patent/JP2017513927A/ja
Publication of JP2017513927A5 publication Critical patent/JP2017513927A5/ja
Pending legal-status Critical Current

Links

JP2016575314A 2014-03-10 2015-03-10 肺の漏出を治療するための自発組織化ペプチド Pending JP2017513927A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461950529P 2014-03-10 2014-03-10
US61/950,529 2014-03-10
US201461953221P 2014-03-14 2014-03-14
US61/953,221 2014-03-14
PCT/US2015/019738 WO2015138473A1 (en) 2014-03-10 2015-03-10 Autoassembling peptides for the treatment of pulmonary leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019194312A Division JP2020011125A (ja) 2014-03-10 2019-10-25 肺の漏出を治療するための自発組織化ペプチド

Publications (2)

Publication Number Publication Date
JP2017513927A JP2017513927A (ja) 2017-06-01
JP2017513927A5 true JP2017513927A5 (enExample) 2018-07-26

Family

ID=52737413

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016575314A Pending JP2017513927A (ja) 2014-03-10 2015-03-10 肺の漏出を治療するための自発組織化ペプチド
JP2019194312A Pending JP2020011125A (ja) 2014-03-10 2019-10-25 肺の漏出を治療するための自発組織化ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019194312A Pending JP2020011125A (ja) 2014-03-10 2019-10-25 肺の漏出を治療するための自発組織化ペプチド

Country Status (5)

Country Link
US (1) US20170173105A1 (enExample)
EP (1) EP3116522B1 (enExample)
JP (2) JP2017513927A (enExample)
ES (1) ES2729214T3 (enExample)
WO (1) WO2015138473A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345433B1 (en) 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP6389170B2 (ja) 2012-07-06 2018-09-12 スリーディー マトリックス, エルティーディー3−D Matrix, Ltd. ペプチド溶液のためのフィル−フィニッシュ過程
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
WO2017120092A1 (en) * 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003517889A (ja) * 1999-12-22 2003-06-03 サージカル シーランツ, インコーポレイテッド 組織の漏出を封止するための方法および組成物
WO2003096972A2 (en) * 2002-05-13 2003-11-27 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
WO2006042161A2 (en) * 2004-10-07 2006-04-20 E.I. Dupont De Nemours And Company Polysaccharide-based polymer tissue adhesive for medical use
CN101472620A (zh) * 2006-04-25 2009-07-01 麻省理工学院 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico

Similar Documents

Publication Publication Date Title
JP2017513927A5 (enExample)
JP2017513928A5 (enExample)
JP2017510400A5 (enExample)
US10952961B2 (en) Implants and constructs including hollow fibers
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP6545727B2 (ja) 肺大気胞を治療するための自発組織化ペプチド
JP2016513523A5 (enExample)
JP2016515113A5 (enExample)
JP2019528320A5 (enExample)
JP2017503852A5 (enExample)
EP3116522B1 (en) Autoassembling peptides for the treatment of pulmonary leakage
Cordery et al. Simultaneous transdermal delivery of buprenorphine hydrochloride and naltrexone hydrochloride by iontophoresis
ES2985515T3 (es) Nuevo régimen de dosificación para polipéptido intestinal vasoactivo inhalado
JP2020510680A5 (enExample)
JP2019518569A5 (enExample)
HRP20161634T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
Djani et al. Congestive heart failure caused by transvenous pacemaker lead prolapse and associated right ventricular outflow tract obstruction in a dog
CN106507666A (zh) 1,3‑丙二磺酸或其药学上可接受的盐用于治疗肉状瘤病的用途
KR102244530B1 (ko) 뇌 및 전신의 재관류 손상을 예방하거나 감소시키기 위한 보호 용액
RU2493827C1 (ru) Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
CN118526697A (zh) 鼻腔给药系统
Murad et al. Therapeutic effects of co-inhaled roflumilast or formoterol and fluticasone on asthma-induced ultrastructural changes in murine airways
US20040220139A1 (en) Inhibiting viral infections
Kim Diagnosis and treatment of idiopathic pulmonary arterial hypertension
Matsuki et al. Heart failure assocated with pregabalin